HEADER TRANSPORT PROTEIN 10-NOV-22 8BLP TITLE HUMAN UREA TRANSPORTER UT-B/UT1 IN COMPLEX WITH INHIBITOR UTBINH-14 COMPND MOL_ID: 1; COMPND 2 MOLECULE: UREA TRANSPORTER 1; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: SOLUTE CARRIER FAMILY 14 MEMBER 1,UREA TRANSPORTER, COMPND 5 ERYTHROCYTE; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: N211A IS AN ENGINEERED MUTATION. THE REST ARE NATURAL COMPND 8 VARIANTS. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC14A1, HUT11, JK, RACH1, UT1, UTE; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SLC14A1, UT1, UT-B, UREA TRANSPORTER, INHIBITOR, SOLUTE CARRIER, KEYWDS 2 TRANSPORT PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR G.CHI,L.DIETZ,A.C.W.PIKE,E.M.MACLEAN,S.M.M.MUKHOPADHYAY,T.BOHSTEDT, AUTHOR 2 D.WANG,A.SCACIOC,G.MCKINLEY,C.H.ARROWSMITH,A.EDWARDS,C.BOUNTRA, AUTHOR 3 A.FERNANDEZ-CID,N.A.BURGESS-BROWN,K.L.DUERR REVDAT 2 11-OCT-23 8BLP 1 SOURCE JRNL REVDAT 1 04-OCT-23 8BLP 0 JRNL AUTH G.CHI,L.DIETZ,H.TANG,M.SNEE,A.SCACIOC,D.WANG,G.MCKINLEY, JRNL AUTH 2 S.M.M.MUKHOPADHYAY,A.C.W.PIKE,R.CHALK,N.A.BURGESS-BROWN, JRNL AUTH 3 J.P.TIMMERMANS,W.VAN PUTTE,C.V.ROBINSON,K.L.DURR JRNL TITL STRUCTURAL CHARACTERIZATION OF HUMAN UREA TRANSPORTERS UT-A JRNL TITL 2 AND UT-B AND THEIR INHIBITION. JRNL REF SCI ADV V. 9 G8229 2023 JRNL REFN ESSN 2375-2548 JRNL PMID 37774028 JRNL DOI 10.1126/SCIADV.ADG8229 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, PHENIX, COOT REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : AB INITIO MODEL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.600 REMARK 3 NUMBER OF PARTICLES : 258739 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8BLP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1292126376. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HOMOTRIMERIC COMPLEX OF HUMAN REMARK 245 UREA TRANSPORTER UT-B REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 3.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 8221 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 SUMMIT (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2600.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 3958.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 30 REMARK 465 GLU A 386 REMARK 465 SER A 387 REMARK 465 PRO A 388 REMARK 465 LEU A 389 REMARK 465 ALA A 390 REMARK 465 GLU A 391 REMARK 465 ASN A 392 REMARK 465 LEU A 393 REMARK 465 TYR A 394 REMARK 465 PHE A 395 REMARK 465 GLN A 396 REMARK 465 MET B 30 REMARK 465 GLU B 386 REMARK 465 SER B 387 REMARK 465 PRO B 388 REMARK 465 LEU B 389 REMARK 465 ALA B 390 REMARK 465 GLU B 391 REMARK 465 ASN B 392 REMARK 465 LEU B 393 REMARK 465 TYR B 394 REMARK 465 PHE B 395 REMARK 465 GLN B 396 REMARK 465 MET C 30 REMARK 465 GLU C 386 REMARK 465 SER C 387 REMARK 465 PRO C 388 REMARK 465 LEU C 389 REMARK 465 ALA C 390 REMARK 465 GLU C 391 REMARK 465 ASN C 392 REMARK 465 LEU C 393 REMARK 465 TYR C 394 REMARK 465 PHE C 395 REMARK 465 GLN C 396 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 31 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 33 CG CD CE NZ REMARK 470 GLN A 211 CG CD OE1 NE2 REMARK 470 ARG A 383 CG CD NE CZ NH1 NH2 REMARK 470 MET A 384 CG SD CE REMARK 470 VAL A 385 CG1 CG2 REMARK 470 PHE B 31 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 33 CG CD CE NZ REMARK 470 GLN B 211 CG CD OE1 NE2 REMARK 470 ARG B 383 CG CD NE CZ NH1 NH2 REMARK 470 MET B 384 CG SD CE REMARK 470 VAL B 385 CG1 CG2 REMARK 470 PHE C 31 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS C 33 CG CD CE NZ REMARK 470 GLN C 211 CG CD OE1 NE2 REMARK 470 ARG C 383 CG CD NE CZ NH1 NH2 REMARK 470 MET C 384 CG SD CE REMARK 470 VAL C 385 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 73 71.04 -105.15 REMARK 500 PHE A 176 -140.83 66.97 REMARK 500 PHE A 197 -62.32 -95.00 REMARK 500 MET A 300 -69.61 -91.85 REMARK 500 CYS A 338 -128.65 59.92 REMARK 500 THR A 368 -73.21 -114.94 REMARK 500 ASN B 73 71.07 -105.15 REMARK 500 PHE B 176 -140.81 66.99 REMARK 500 PHE B 197 -62.39 -94.96 REMARK 500 MET B 300 -69.65 -91.86 REMARK 500 CYS B 338 -128.70 59.99 REMARK 500 THR B 368 -73.21 -114.95 REMARK 500 ASN C 73 71.08 -105.18 REMARK 500 PHE C 176 -140.85 66.93 REMARK 500 PHE C 197 -62.29 -94.99 REMARK 500 MET C 300 -69.67 -91.82 REMARK 500 CYS C 338 -128.61 59.95 REMARK 500 THR C 368 -73.22 -114.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PTY A 401 REMARK 610 LMT A 402 REMARK 610 LMT A 403 REMARK 610 LMT A 404 REMARK 610 LMT A 405 REMARK 610 LMT A 406 REMARK 610 PTY A 407 REMARK 610 LMT A 408 REMARK 610 LMT A 409 REMARK 610 LMT A 410 REMARK 610 LMT A 411 REMARK 610 LMT A 412 REMARK 610 LMT A 413 REMARK 610 LMT A 414 REMARK 610 LMT A 415 REMARK 610 LMT A 416 REMARK 610 LMT A 417 REMARK 610 LMT A 418 REMARK 610 LMT A 422 REMARK 610 LMT B 402 REMARK 610 PTY B 403 REMARK 610 LMT B 404 REMARK 610 LMT B 405 REMARK 610 LMT B 406 REMARK 610 LMT B 407 REMARK 610 LMT B 408 REMARK 610 PTY B 409 REMARK 610 LMT B 410 REMARK 610 LMT B 411 REMARK 610 LMT B 412 REMARK 610 LMT B 413 REMARK 610 LMT B 414 REMARK 610 LMT B 415 REMARK 610 LMT B 416 REMARK 610 LMT B 417 REMARK 610 LMT B 418 REMARK 610 LMT B 419 REMARK 610 LMT B 420 REMARK 610 LMT C 402 REMARK 610 PTY C 403 REMARK 610 LMT C 404 REMARK 610 LMT C 405 REMARK 610 LMT C 406 REMARK 610 LMT C 407 REMARK 610 LMT C 408 REMARK 610 PTY C 409 REMARK 610 LMT C 410 REMARK 610 LMT C 411 REMARK 610 LMT C 412 REMARK 610 LMT C 413 REMARK 610 LMT C 414 REMARK 610 LMT C 415 REMARK 610 LMT C 416 REMARK 610 LMT C 417 REMARK 610 LMT C 418 REMARK 610 LMT C 419 REMARK 610 LMT C 420 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-16110 RELATED DB: EMDB REMARK 900 THIS DEPOSITION AND THE RELATED ENTRIES WILL BE PART OF ONE REMARK 900 PUBLICATION. REMARK 900 RELATED ID: EMD-16111 RELATED DB: EMDB REMARK 900 THIS DEPOSITION AND THE RELATED ENTRIES WILL BE PART OF ONE REMARK 900 PUBLICATION. REMARK 900 RELATED ID: EMD-16112 RELATED DB: EMDB REMARK 900 HUMAN UREA TRANSPORTER UT-B/UT1 IN COMPLEX WITH INHIBITOR UTBINH-14 DBREF 8BLP A 31 389 UNP Q13336 UT1_HUMAN 31 389 DBREF 8BLP B 31 389 UNP Q13336 UT1_HUMAN 31 389 DBREF 8BLP C 31 389 UNP Q13336 UT1_HUMAN 31 389 SEQADV 8BLP MET A 30 UNP Q13336 INITIATING METHIONINE SEQADV 8BLP VAL A 167 UNP Q13336 MET 167 CONFLICT SEQADV 8BLP GLN A 211 UNP Q13336 ASN 211 ENGINEERED MUTATION SEQADV 8BLP ASN A 280 UNP Q13336 ASP 280 CONFLICT SEQADV 8BLP ALA A 390 UNP Q13336 EXPRESSION TAG SEQADV 8BLP GLU A 391 UNP Q13336 EXPRESSION TAG SEQADV 8BLP ASN A 392 UNP Q13336 EXPRESSION TAG SEQADV 8BLP LEU A 393 UNP Q13336 EXPRESSION TAG SEQADV 8BLP TYR A 394 UNP Q13336 EXPRESSION TAG SEQADV 8BLP PHE A 395 UNP Q13336 EXPRESSION TAG SEQADV 8BLP GLN A 396 UNP Q13336 EXPRESSION TAG SEQADV 8BLP MET B 30 UNP Q13336 INITIATING METHIONINE SEQADV 8BLP VAL B 167 UNP Q13336 MET 167 CONFLICT SEQADV 8BLP GLN B 211 UNP Q13336 ASN 211 ENGINEERED MUTATION SEQADV 8BLP ASN B 280 UNP Q13336 ASP 280 CONFLICT SEQADV 8BLP ALA B 390 UNP Q13336 EXPRESSION TAG SEQADV 8BLP GLU B 391 UNP Q13336 EXPRESSION TAG SEQADV 8BLP ASN B 392 UNP Q13336 EXPRESSION TAG SEQADV 8BLP LEU B 393 UNP Q13336 EXPRESSION TAG SEQADV 8BLP TYR B 394 UNP Q13336 EXPRESSION TAG SEQADV 8BLP PHE B 395 UNP Q13336 EXPRESSION TAG SEQADV 8BLP GLN B 396 UNP Q13336 EXPRESSION TAG SEQADV 8BLP MET C 30 UNP Q13336 INITIATING METHIONINE SEQADV 8BLP VAL C 167 UNP Q13336 MET 167 CONFLICT SEQADV 8BLP GLN C 211 UNP Q13336 ASN 211 ENGINEERED MUTATION SEQADV 8BLP ASN C 280 UNP Q13336 ASP 280 CONFLICT SEQADV 8BLP ALA C 390 UNP Q13336 EXPRESSION TAG SEQADV 8BLP GLU C 391 UNP Q13336 EXPRESSION TAG SEQADV 8BLP ASN C 392 UNP Q13336 EXPRESSION TAG SEQADV 8BLP LEU C 393 UNP Q13336 EXPRESSION TAG SEQADV 8BLP TYR C 394 UNP Q13336 EXPRESSION TAG SEQADV 8BLP PHE C 395 UNP Q13336 EXPRESSION TAG SEQADV 8BLP GLN C 396 UNP Q13336 EXPRESSION TAG SEQRES 1 A 367 MET PHE PRO LYS ALA LEU GLY TYR VAL THR GLY ASP MET SEQRES 2 A 367 LYS GLU LEU ALA ASN GLN LEU LYS ASP LYS PRO VAL VAL SEQRES 3 A 367 LEU GLN PHE ILE ASP TRP ILE LEU ARG GLY ILE SER GLN SEQRES 4 A 367 VAL VAL PHE VAL ASN ASN PRO VAL SER GLY ILE LEU ILE SEQRES 5 A 367 LEU VAL GLY LEU LEU VAL GLN ASN PRO TRP TRP ALA LEU SEQRES 6 A 367 THR GLY TRP LEU GLY THR VAL VAL SER THR LEU MET ALA SEQRES 7 A 367 LEU LEU LEU SER GLN ASP ARG SER LEU ILE ALA SER GLY SEQRES 8 A 367 LEU TYR GLY TYR ASN ALA THR LEU VAL GLY VAL LEU MET SEQRES 9 A 367 ALA VAL PHE SER ASP LYS GLY ASP TYR PHE TRP TRP LEU SEQRES 10 A 367 LEU LEU PRO VAL CYS ALA MET SER MET THR CYS PRO ILE SEQRES 11 A 367 PHE SER SER ALA LEU ASN SER VAL LEU SER LYS TRP ASP SEQRES 12 A 367 LEU PRO VAL PHE THR LEU PRO PHE ASN MET ALA LEU SER SEQRES 13 A 367 MET TYR LEU SER ALA THR GLY HIS TYR ASN PRO PHE PHE SEQRES 14 A 367 PRO ALA LYS LEU VAL ILE PRO ILE THR THR ALA PRO GLN SEQRES 15 A 367 ILE SER TRP SER ASP LEU SER ALA LEU GLU LEU LEU LYS SEQRES 16 A 367 SER ILE PRO VAL GLY VAL GLY GLN ILE TYR GLY CYS ASP SEQRES 17 A 367 ASN PRO TRP THR GLY GLY ILE PHE LEU GLY ALA ILE LEU SEQRES 18 A 367 LEU SER SER PRO LEU MET CYS LEU HIS ALA ALA ILE GLY SEQRES 19 A 367 SER LEU LEU GLY ILE ALA ALA GLY LEU SER LEU SER ALA SEQRES 20 A 367 PRO PHE GLU ASN ILE TYR PHE GLY LEU TRP GLY PHE ASN SEQRES 21 A 367 SER SER LEU ALA CYS ILE ALA MET GLY GLY MET PHE MET SEQRES 22 A 367 ALA LEU THR TRP GLN THR HIS LEU LEU ALA LEU GLY CYS SEQRES 23 A 367 ALA LEU PHE THR ALA TYR LEU GLY VAL GLY MET ALA ASN SEQRES 24 A 367 PHE MET ALA GLU VAL GLY LEU PRO ALA CYS THR TRP PRO SEQRES 25 A 367 PHE CYS LEU ALA THR LEU LEU PHE LEU ILE MET THR THR SEQRES 26 A 367 LYS ASN SER ASN ILE TYR LYS MET PRO LEU SER LYS VAL SEQRES 27 A 367 THR TYR PRO GLU GLU ASN ARG ILE PHE TYR LEU GLN ALA SEQRES 28 A 367 LYS LYS ARG MET VAL GLU SER PRO LEU ALA GLU ASN LEU SEQRES 29 A 367 TYR PHE GLN SEQRES 1 B 367 MET PHE PRO LYS ALA LEU GLY TYR VAL THR GLY ASP MET SEQRES 2 B 367 LYS GLU LEU ALA ASN GLN LEU LYS ASP LYS PRO VAL VAL SEQRES 3 B 367 LEU GLN PHE ILE ASP TRP ILE LEU ARG GLY ILE SER GLN SEQRES 4 B 367 VAL VAL PHE VAL ASN ASN PRO VAL SER GLY ILE LEU ILE SEQRES 5 B 367 LEU VAL GLY LEU LEU VAL GLN ASN PRO TRP TRP ALA LEU SEQRES 6 B 367 THR GLY TRP LEU GLY THR VAL VAL SER THR LEU MET ALA SEQRES 7 B 367 LEU LEU LEU SER GLN ASP ARG SER LEU ILE ALA SER GLY SEQRES 8 B 367 LEU TYR GLY TYR ASN ALA THR LEU VAL GLY VAL LEU MET SEQRES 9 B 367 ALA VAL PHE SER ASP LYS GLY ASP TYR PHE TRP TRP LEU SEQRES 10 B 367 LEU LEU PRO VAL CYS ALA MET SER MET THR CYS PRO ILE SEQRES 11 B 367 PHE SER SER ALA LEU ASN SER VAL LEU SER LYS TRP ASP SEQRES 12 B 367 LEU PRO VAL PHE THR LEU PRO PHE ASN MET ALA LEU SER SEQRES 13 B 367 MET TYR LEU SER ALA THR GLY HIS TYR ASN PRO PHE PHE SEQRES 14 B 367 PRO ALA LYS LEU VAL ILE PRO ILE THR THR ALA PRO GLN SEQRES 15 B 367 ILE SER TRP SER ASP LEU SER ALA LEU GLU LEU LEU LYS SEQRES 16 B 367 SER ILE PRO VAL GLY VAL GLY GLN ILE TYR GLY CYS ASP SEQRES 17 B 367 ASN PRO TRP THR GLY GLY ILE PHE LEU GLY ALA ILE LEU SEQRES 18 B 367 LEU SER SER PRO LEU MET CYS LEU HIS ALA ALA ILE GLY SEQRES 19 B 367 SER LEU LEU GLY ILE ALA ALA GLY LEU SER LEU SER ALA SEQRES 20 B 367 PRO PHE GLU ASN ILE TYR PHE GLY LEU TRP GLY PHE ASN SEQRES 21 B 367 SER SER LEU ALA CYS ILE ALA MET GLY GLY MET PHE MET SEQRES 22 B 367 ALA LEU THR TRP GLN THR HIS LEU LEU ALA LEU GLY CYS SEQRES 23 B 367 ALA LEU PHE THR ALA TYR LEU GLY VAL GLY MET ALA ASN SEQRES 24 B 367 PHE MET ALA GLU VAL GLY LEU PRO ALA CYS THR TRP PRO SEQRES 25 B 367 PHE CYS LEU ALA THR LEU LEU PHE LEU ILE MET THR THR SEQRES 26 B 367 LYS ASN SER ASN ILE TYR LYS MET PRO LEU SER LYS VAL SEQRES 27 B 367 THR TYR PRO GLU GLU ASN ARG ILE PHE TYR LEU GLN ALA SEQRES 28 B 367 LYS LYS ARG MET VAL GLU SER PRO LEU ALA GLU ASN LEU SEQRES 29 B 367 TYR PHE GLN SEQRES 1 C 367 MET PHE PRO LYS ALA LEU GLY TYR VAL THR GLY ASP MET SEQRES 2 C 367 LYS GLU LEU ALA ASN GLN LEU LYS ASP LYS PRO VAL VAL SEQRES 3 C 367 LEU GLN PHE ILE ASP TRP ILE LEU ARG GLY ILE SER GLN SEQRES 4 C 367 VAL VAL PHE VAL ASN ASN PRO VAL SER GLY ILE LEU ILE SEQRES 5 C 367 LEU VAL GLY LEU LEU VAL GLN ASN PRO TRP TRP ALA LEU SEQRES 6 C 367 THR GLY TRP LEU GLY THR VAL VAL SER THR LEU MET ALA SEQRES 7 C 367 LEU LEU LEU SER GLN ASP ARG SER LEU ILE ALA SER GLY SEQRES 8 C 367 LEU TYR GLY TYR ASN ALA THR LEU VAL GLY VAL LEU MET SEQRES 9 C 367 ALA VAL PHE SER ASP LYS GLY ASP TYR PHE TRP TRP LEU SEQRES 10 C 367 LEU LEU PRO VAL CYS ALA MET SER MET THR CYS PRO ILE SEQRES 11 C 367 PHE SER SER ALA LEU ASN SER VAL LEU SER LYS TRP ASP SEQRES 12 C 367 LEU PRO VAL PHE THR LEU PRO PHE ASN MET ALA LEU SER SEQRES 13 C 367 MET TYR LEU SER ALA THR GLY HIS TYR ASN PRO PHE PHE SEQRES 14 C 367 PRO ALA LYS LEU VAL ILE PRO ILE THR THR ALA PRO GLN SEQRES 15 C 367 ILE SER TRP SER ASP LEU SER ALA LEU GLU LEU LEU LYS SEQRES 16 C 367 SER ILE PRO VAL GLY VAL GLY GLN ILE TYR GLY CYS ASP SEQRES 17 C 367 ASN PRO TRP THR GLY GLY ILE PHE LEU GLY ALA ILE LEU SEQRES 18 C 367 LEU SER SER PRO LEU MET CYS LEU HIS ALA ALA ILE GLY SEQRES 19 C 367 SER LEU LEU GLY ILE ALA ALA GLY LEU SER LEU SER ALA SEQRES 20 C 367 PRO PHE GLU ASN ILE TYR PHE GLY LEU TRP GLY PHE ASN SEQRES 21 C 367 SER SER LEU ALA CYS ILE ALA MET GLY GLY MET PHE MET SEQRES 22 C 367 ALA LEU THR TRP GLN THR HIS LEU LEU ALA LEU GLY CYS SEQRES 23 C 367 ALA LEU PHE THR ALA TYR LEU GLY VAL GLY MET ALA ASN SEQRES 24 C 367 PHE MET ALA GLU VAL GLY LEU PRO ALA CYS THR TRP PRO SEQRES 25 C 367 PHE CYS LEU ALA THR LEU LEU PHE LEU ILE MET THR THR SEQRES 26 C 367 LYS ASN SER ASN ILE TYR LYS MET PRO LEU SER LYS VAL SEQRES 27 C 367 THR TYR PRO GLU GLU ASN ARG ILE PHE TYR LEU GLN ALA SEQRES 28 C 367 LYS LYS ARG MET VAL GLU SER PRO LEU ALA GLU ASN LEU SEQRES 29 C 367 TYR PHE GLN HET PTY A 401 46 HET LMT A 402 25 HET LMT A 403 25 HET LMT A 404 8 HET LMT A 405 11 HET LMT A 406 8 HET PTY A 407 40 HET LMT A 408 12 HET LMT A 409 13 HET LMT A 410 11 HET LMT A 411 8 HET LMT A 412 8 HET LMT A 413 12 HET LMT A 414 8 HET LMT A 415 23 HET LMT A 416 11 HET LMT A 417 23 HET LMT A 418 7 HET 5D3 A 419 30 HET 5D3 A 420 30 HET Y01 A 421 35 HET LMT A 422 11 HET Y01 B 401 35 HET LMT B 402 11 HET PTY B 403 46 HET LMT B 404 25 HET LMT B 405 25 HET LMT B 406 8 HET LMT B 407 11 HET LMT B 408 8 HET PTY B 409 40 HET LMT B 410 12 HET LMT B 411 13 HET LMT B 412 11 HET LMT B 413 8 HET LMT B 414 8 HET LMT B 415 12 HET LMT B 416 8 HET LMT B 417 23 HET LMT B 418 11 HET LMT B 419 23 HET LMT B 420 7 HET 5D3 B 421 30 HET 5D3 B 422 30 HET Y01 C 401 35 HET LMT C 402 11 HET PTY C 403 46 HET LMT C 404 25 HET LMT C 405 25 HET LMT C 406 8 HET LMT C 407 11 HET LMT C 408 8 HET PTY C 409 40 HET LMT C 410 12 HET LMT C 411 13 HET LMT C 412 11 HET LMT C 413 8 HET LMT C 414 8 HET LMT C 415 12 HET LMT C 416 8 HET LMT C 417 23 HET LMT C 418 11 HET LMT C 419 23 HET LMT C 420 7 HET 5D3 C 421 30 HET 5D3 C 422 30 HETNAM PTY PHOSPHATIDYLETHANOLAMINE HETNAM LMT DODECYL-BETA-D-MALTOSIDE HETNAM 5D3 10-(4-ETHYLPHENYL)SULFONYL-~{N}-(THIOPHEN-2-YLMETHYL)- HETNAM 2 5D3 5-THIA-1,8,11,12-TETRAZATRICYCLO[7.3.0.0^{2,6}]DODECA- HETNAM 3 5D3 2(6),3,7,9,11-PENTAEN-7-AMINE HETNAM Y01 CHOLESTEROL HEMISUCCINATE FORMUL 4 PTY 6(C40 H80 N O8 P) FORMUL 5 LMT 51(C24 H46 O11) FORMUL 22 5D3 6(C20 H17 N5 O2 S3) FORMUL 24 Y01 3(C31 H50 O4) FORMUL 70 HOH *66(H2 O) HELIX 1 AA1 PHE A 31 THR A 39 1 9 HELIX 2 AA2 MET A 42 LYS A 52 1 11 HELIX 3 AA3 PRO A 53 GLN A 68 1 16 HELIX 4 AA4 VAL A 69 PHE A 71 5 3 HELIX 5 AA5 ASN A 74 ASN A 89 1 16 HELIX 6 AA6 ASN A 89 LEU A 110 1 22 HELIX 7 AA7 ASP A 113 SER A 119 1 7 HELIX 8 AA8 GLY A 123 PHE A 136 1 14 HELIX 9 AA9 PHE A 143 TRP A 145 5 3 HELIX 10 AB1 LEU A 146 TRP A 171 1 26 HELIX 11 AB2 THR A 177 GLY A 192 1 16 HELIX 12 AB3 SER A 213 LEU A 217 5 5 HELIX 13 AB4 SER A 218 ILE A 233 1 16 HELIX 14 AB5 ASN A 238 SER A 253 1 16 HELIX 15 AB6 SER A 253 LEU A 274 1 22 HELIX 16 AB7 PRO A 277 PHE A 283 1 7 HELIX 17 AB8 GLY A 287 GLY A 298 1 12 HELIX 18 AB9 THR A 305 ALA A 331 1 27 HELIX 19 AC1 THR A 339 MET A 352 1 14 HELIX 20 AC2 PRO A 363 VAL A 367 5 5 HELIX 21 AC3 TYR A 369 VAL A 385 1 17 HELIX 22 AC4 PRO B 32 THR B 39 1 8 HELIX 23 AC5 MET B 42 LYS B 52 1 11 HELIX 24 AC6 PRO B 53 GLN B 68 1 16 HELIX 25 AC7 VAL B 69 PHE B 71 5 3 HELIX 26 AC8 ASN B 74 ASN B 89 1 16 HELIX 27 AC9 ASN B 89 LEU B 110 1 22 HELIX 28 AD1 ASP B 113 SER B 119 1 7 HELIX 29 AD2 GLY B 123 PHE B 136 1 14 HELIX 30 AD3 PHE B 143 TRP B 145 5 3 HELIX 31 AD4 LEU B 146 TRP B 171 1 26 HELIX 32 AD5 THR B 177 GLY B 192 1 16 HELIX 33 AD6 SER B 213 LEU B 217 5 5 HELIX 34 AD7 SER B 218 ILE B 233 1 16 HELIX 35 AD8 ASN B 238 SER B 253 1 16 HELIX 36 AD9 SER B 253 LEU B 274 1 22 HELIX 37 AE1 PRO B 277 PHE B 283 1 7 HELIX 38 AE2 GLY B 287 GLY B 298 1 12 HELIX 39 AE3 THR B 305 ALA B 331 1 27 HELIX 40 AE4 THR B 339 MET B 352 1 14 HELIX 41 AE5 PRO B 363 VAL B 367 5 5 HELIX 42 AE6 TYR B 369 VAL B 385 1 17 HELIX 43 AE7 PRO C 32 THR C 39 1 8 HELIX 44 AE8 MET C 42 LYS C 52 1 11 HELIX 45 AE9 PRO C 53 GLN C 68 1 16 HELIX 46 AF1 VAL C 69 PHE C 71 5 3 HELIX 47 AF2 ASN C 74 ASN C 89 1 16 HELIX 48 AF3 ASN C 89 LEU C 110 1 22 HELIX 49 AF4 ASP C 113 SER C 119 1 7 HELIX 50 AF5 GLY C 123 PHE C 136 1 14 HELIX 51 AF6 PHE C 143 TRP C 145 5 3 HELIX 52 AF7 LEU C 146 TRP C 171 1 26 HELIX 53 AF8 THR C 177 GLY C 192 1 16 HELIX 54 AF9 SER C 213 LEU C 217 5 5 HELIX 55 AG1 SER C 218 ILE C 233 1 16 HELIX 56 AG2 ASN C 238 SER C 253 1 16 HELIX 57 AG3 SER C 253 LEU C 274 1 22 HELIX 58 AG4 PRO C 277 PHE C 283 1 7 HELIX 59 AG5 GLY C 287 GLY C 298 1 12 HELIX 60 AG6 THR C 305 ALA C 331 1 27 HELIX 61 AG7 THR C 339 MET C 352 1 14 HELIX 62 AG8 PRO C 363 VAL C 367 5 5 HELIX 63 AG9 TYR C 369 VAL C 385 1 17 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000